Alkem Laboratories Limited (ALKEM) — Related Party Transaction
Alkem Laboratories announced it acquired 79,36,50,794 equity shares in Alkem Medtech Private Limited at Rs. 13.86 per share for a total consideration of Rs. 11,00,00,00,005, representing up to 55% of Occlutech Holding AG. The transaction was completed on 15 July 2026 and is disclosed under SEBI LODR Regulation 30.
About Alkem Laboratories Limited (ALKEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ALKEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ALKEM — Free💡 Ask AI about this filing
📊 More ALKEM filings
- 🔴 Corporate Action — 15 July 2026 Alkem Laboratories announced a shareholders' meeting on August 17, 2026, to approve a scheme of amal...
- Announcement — 1 July 2026 Alkem Laboratories disclosed favorable tax appeal orders from the Commissioner of Income Tax (Appeal...
- Announcement — 29 June 2026 Alkem Laboratories announced that its wholly owned subsidiary Alkem Medtech executed a First Supplem...
- Announcement — 29 June 2026 Alkem Laboratories announced an upcoming analyst and institutional investor meeting scheduled for Ju...
- Financial Results — 24 June 2026 Alkem Laboratories has announced that its trading window will close on 29 June 2026 and remain close...
🔥 Also filed on 16 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ALKEM files new disclosures
Track ALKEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ALKEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research